Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiolo...

Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiolo...

Credit Morning 05/16/2025

Reportedly, Bayer thinks about sending Monsanto into chapter 11 to solve litigation|Teva: Moody’s upgrades the rating to Ba1/stable from Ba2/positive|Techem Q2 25 call notes: Likely no imminent call of EUR 750 Temporary Notes|Crédit Logement released its 2024 results|BFCM announces the call for its Perp CMS on 16/06/2025|

Morning Crédit 16/05/2025

Reportedly, Bayer thinks about sending Monsanto into chapter 11 to solve litigation|Teva : Moody’s rehausse le rating de Ba2/positive à Ba1/stable|Techem Q2 25 call notes: Likely no imminent call of EUR 750 Temporary Notes|Crédit Logement a publié ses résultats 2024|BFCM annonce le call de son Perp CMS à la date du 16/06/2025|

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 05/15/2025

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 15/05/2025

Credit Morning 05/15/2025

Maxeda: solid Q4 results and Q1 expected to be strong. Further bond buybacks.|Ubisoft: sharp decline in 2024/25 earnings, no rebound expected in 2025/26|Forvia is considering selling its spare parts division|Techem Q2 25 results: Good earnings print; ownership change and mandatory call remain open|

Morning Crédit 15/05/2025

Maxeda : de bons résultats T4 et un T1 qui devrait l’être tout autant. Poursuite des rachats de dettes.|Ubisoft : résultats 2024/25 en forte baisse, pas de rebond attendu en 2025/26|Forvia envisagerait la cession de sa division de pièces détachées|Techem Q2 25 results: Good earnings print; ownership change and mandatory call remain open|

Merck KGaA : Q1 review – strong performance in Process solutions, guid...

Moody's Ratings assigns A2 rating to Pfizer's subsidiary notes offerin...

Moody's Ratings ("Moody's") assigned a A2 rating to the proposed euro-denominated senior unsecured notes offering by Pfizer Netherlands International Finance B.V. (PNIF BV), a wholly-owned subsidiary of Pfizer Inc. (Pfizer). We also assigned a stable outlook to PNIF BV. The A2 rating assigned to P...

Credit Morning 05/14/2025

URW (Investor Day): Focus on growth and shareholder value|Atos unveils ambitious 2028 targets that will be presented during an Investor Day|

Morning Crédit 14/05/2025

URW (journée investisseurs) : place à la croissance et à la rémunération des actionnaires|Atos dévoile des objectifs 2028 ambitieux dans le cadre de son Investor Day|

BAYER: MENSAJES DE LA CONFERENCE CALL RDOS. 1T’25 (ANÁLISIS BANCO SABA...

De la conference call de Rdos. 1T’25 destacamos:

Nearing EMPEROR Kickoff, An In-Line 1Q25 Update

Credit Morning 05/13/2025

Cellnex issues € 750m of new 2032 notes|Grifols : Q1 2025 earnings above expectations, FY guidance maintained despite weaker US dollar|90-day truce in the trade war between the United States and China|

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 05/13/2025

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 13/05/2025

Morning Crédit 13/05/2025

Cellnex émet 750 m EUR de nouvelles obligations 2032|Grifols : résultats supérieurs aux attentes au T1 2025, guidance annuelle confirmée malgré la dépréciation du dollar US|Trêve de 90 jours dans la guerre commerciale entre les Etats-Unis et la Chine|

Bayer : Strong Pharma division performance despite sharp decline in Xa...

BAYER: RDOS. 1T’25 Y CAMBIO DE P.O. A LA BAJA (ANÁLISIS BANCO SABADELL...

Rdos. 1T'25 vs 1T'24: Ventas: 13.738 M euros (-0,2% vs -2,0% BS(e) y -1,8% consenso); EBITDA: 4.085 M euros (-7,4% vs -15,5% BS(e) y -15,0% consenso).